solasia.co.jp
archives
This URL has 1 public saves. The first save was Apr 21, 2026, 04:36 PM and the latest save was Apr 21, 2026, 04:36 PM.
View recent saves on this domain
Latest saved version
ソレイジア・ファーマ株式会社│がんと向き合う人たちのために
This is the newest public snapshot for this URL and the best place to start reviewing the page.
Source URL
https://solasia.co.jp/
About this page
This page presents Solasia Pharma K.K., a pharmaceutical company specializing in cancer treatment. The company aims to illuminate the future for cancer patients by understanding unspoken patient needs and developing innovative medicines. Key strengths include deep expertise in oncology, understanding patient perspectives, and agile decision-making. Approved products include Sancuso® for chemotherapy-induced nausea/vomiting, Darvadstrocel® for peripheral T-cell lymphoma, and Episil® for chemotherapy-induced oral mucositis. Pipeline candidates include SP-04 for peripheral neuropathy and SP-05 for colorectal cancer, with development progressing across multiple regions.
Saved versions
solasia.co.jp web archives are listed here. You can still review the saved screenshot and HTML even if the original page disappears.